Skip to main content
. Author manuscript; available in PMC: 2022 Nov 20.
Published in final edited form as: J Psychosoc Oncol. 2021 Sep 6;40(6):868–880. doi: 10.1080/07347332.2021.1971816

Table 1.

Patient, disease, and treatment characteristics at diagnosis

Rural N = 249
Sex
 Male 160 (64.3%)
 Female 89 (35.7%)
Age
 Mean (SD); range 60.7 (12.3); 25–93
Race
 White 235 (94.4%)
 Black 3 (1.2%)
 Other 11 (4.4%)
Stage
 Early (0–2) 96 (38.6%)
 Advanced (3–4) 138 (55.4%)
 Not stageable/unknown 15 (6.0%)
Site
 Oral cavity 94 (37.8%)
 Oropharynx 51 (20.5%)
 Hypopharynx 9 (3.6%)
 Larynx 58 (23.3%)
 Else/unknown 37 (14.8%)
Treatment
 Surgery only 89 (35.7%)
 Chemotherapy only 0 (0%)
 Radiotherapy only 30 (12.0%)
 Combination 109 (43.9%)
 Other/unknown 21 (8.4%)
SMAST score (Mean/SD); range 2.09 (2.92); 0–13
 0–1 150 (60.2%)
 2 37 (14.9%)
 3+ 62 (24.9%)
Smoking Status
 Current 74 (29.7%)
 Previous 117 (47.0%)
 Never 58 (23.3%)
BDI score (Mean/SD); range 8.45 (7.60); 0–46
 Minimal (0–9) 162 (65.1%)
 Mild (10–18) 70 (28.1%)
 Moderate (19–29) 12 (4.8%)
 Severe (30+) 5 (2.0%)

Note: T-tests and chi-square test used as appropriate; BDI = Beck Depression Inventory; SMAST = Short Michigan Alcoholism Screening Test